DC Vaccine Enhances CAR-T Cell Antitumor Activity by Overcoming T Cell Exhaustion and Promoting T Cell Infiltration in Solid Tumors

Investigators demonstrated that dendritic cell (DC) vaccines could promote CAR-T therapy in solid tumors, which provided the possibility of widespread clinical application of CAR-T cells in the future.